We believe that no infant, child, or adolescent should die as a result of this potentially fatal infection.
The Meningitis B vaccine has been available and accessible in Canada since 2014. Your insurance provider MAY cover the cost. Talk to a pharmacist or doctor TODAY.
Meningitis B is the most common and most deadly strain of Meningitis.
When a person is infected with MenB, it’s a race against time to begin treatment and start antibiotics. The infection can spread quickly through the bloodstream and attack the brain. 1 in 5 people who contract MenB can experience permanent complications, including brain damage, hearing loss, neurological disorders, or limb loss. 1 in 10 cases can be fatal, often within 24 to 48 hours after the onset of symptoms.
Think you’re protected from Meningitis B? Think again.
Two different Meningitis vaccinations are required for complete protection against Meningococcal disease: the MenACWY vaccine and the MenB vaccine. In Nova Scotia, the MenACWY vaccine is administered in 7th grade as part of the standard vaccination schedule. The MenB vaccine is NOT. To receive the MenB immunization, you must pay for it out-of-pocket or check and see if your insurance covers the cost. Getting BOTH vaccines is the best way to protect yourself and your loved ones.
Help us protect those at-risk by promoting awareness and supporting meningitis B vaccinations at Universities across Nova Scotia.
If it only takes one person to make a difference, let Kai’s death be the reason for change.
Kai was a 19-year-old Kinesiology student who had just finished his first year at Acadia University. He saw and experienced the natural joys of life during his 19 years. He found true love, travelled the world, showcased his natural athletic abilities for all sports, and pursued an education focused on his passions. His calm and gentle demeanour, as well as his charisma and charm, drew everyone towards him. Kai left an ever-lasting mark on everyone who had the pleasure of knowing him.
for meningitis B
Share this page
Join us in our fight against meningitis B.
Sign up to receive more information as we continue to B bold.